TR
Rhelion Life Sciences Corp.
TRUFF · OTC
$0.02 +4.42% (+$0.00)
1M +10.63%
Market Cap $13.6M
P/E Ratio -
Div. Yield -
ROE 43.00%
Piotroski F-Score Weak
2/9Valuation
71 /100
Cheap P/B 0.72x
P/S 4.40x
P/FFO N/A
Growth
23 /100
Declining Book val. growth 22.86%
Rev. growth 2.03%
FCF growth N/A
Profitability
14 /100
Weak Op. margin 263.74%
Gross margin 36.80%
FCF margin 129.94%
Quality
2 /100
Poor ROA 30.04%
ROIC 42.04%
Asset turnover 0.14x
Debt
69 /100
Low Int. coverage -97.77x
Debt/Equity 0.02x
Current ratio 3.25x
Stability
47 /100
Moderate EPS volatility 67.06%
Beta 0.96x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre TRUFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Todd Michael Shapiro
Employees
104
Headquarters
Toronto
Evenimente viitoare
30 NOV.
Earnings
Upcoming earnings report